Rock Creek Pharmaceuticals, Inc. (RCPIQ) Stock Analysis
DELISTED
What happened to Rock Creek Pharmaceuticals, Inc. (RCPIQ) stock?
Rock Creek Pharmaceuticals, Inc. (RCPIQ) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Rock Creek Pharmaceuticals, Inc. (RCPIQ). Rock Creek Pharmaceuticals, Inc. is a pharmaceutical development company focused on therapies for chronic inflammatory diseases and neurologic disorders. Their lead compound, Anatabine citrate, is a small molecule cholinergic agonist with anti-inflammatory properties.
Last analyzed: Mar 18, 2026Rock Creek Pharmaceuticals, Inc. (RCPIQ) Healthcare & Pipeline Overview
RCPIQ OTC Market Information
RCPIQ trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy RCPIQ shares?
No. RCPIQ stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for RCPIQ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before RCPIQ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Rock Creek Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.